Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arkray USA launches "new, improved" version of glucose monitoring test strips

This article was originally published in Clinica

Executive Summary

Arkray USA has launched a "new and improved" Assure Pro blood glucose monitoring test strip. The new product requires 0.5 microlitres of blood, compared with 1 microlitre with the previous version. It also exceeds the US FDA's proposed increased accuracy guidelines, the Edina, Minnesota-based division of the Japanese diagnostics firm claims. In a recent study, 100% of results fall within 15% of those from a lab test, and 98% fall within 10%. The Assure Pro blood glucose monitoring system is designed for long-term care and multi-resident settings.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044747

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel